Geert Cauwenbergh

2022

In 2022, Geert Cauwenbergh earned a total compensation of $77.4K as Former interim Principal Executive and Financial Officer at RXi Pharmaceuticals, a 33% increase compared to previous year.

Compensation breakdown

Salary$68,750
Stock Awards$8,612
Total$77,362

Cauwenbergh received $68.8K in salary, accounting for 89% of the total pay in 2022.

Cauwenbergh also received $8.6K in stock awards.

Rankings

In 2022, Geert Cauwenbergh's compensation ranked 5,647th out of 5,760 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 2.0% of executives.

ClassificationRankingPercentile
All
5,647
out of 5,760
2nd
Division
Manufacturing
3,082
out of 3,136
2nd
Major group
Chemicals And Allied Products
1,403
out of 1,422
1st
Industry group
Drugs
1,308
out of 1,323
1st
Industry
Pharmaceutical Preparations
956
out of 969
1st
Source: SEC filing on June 9, 2023.

Cauwenbergh's colleagues

We found two more compensation records of executives who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2022.

2022

Gerrit Dispersyn

RXi Pharmaceuticals

Chief Executive Officer

2022

Robert Bitterman

RXi Pharmaceuticals

Chief Executive Officer

News

You may also like